Medtech start-up Axio Biosolutions on Thursday said it has raised Rs36 crores ($5.2 million) in a Series B-1 round of funding, led by Omidyar Network India, along with participation from existing investors Accel, University of California & Ratan Tata’s UC-RNT Fund and Chiratae Ventures.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
